- Pharmaceutical development of a lyophilised dosage form for the investigational anticancer agent Imexon using dimethyl sulfoxide as solubilising and stabilising agent. den Brok, M.W., Nuijen, B., Lutz, C., Opitz, H.G., Beijnen, J.H. Journal of pharmaceutical sciences. (2005)